PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

Part of paid clinical trials in New Orleans, Louisiana.

Sponsor
Tulane University
Study ID
NCT04843371
Status
Recruiting
Apply to this trial

Conditions

  • Cardiomyopathies
  • Pericardial Disease
  • Valvular Heart Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - 120 Years
Healthy Volunteers
Accepted

Interventions

  • Photoplethysmography — DIAGNOSTIC_TEST
    Photoplethysmography (PPG) is a non-invasive technique that can detect volumetric changes in the peripheral blood. It only requires skin contact and relies on light absorption. PPG is a good indicator of the cardiovascular dynamics in the human body. PPG has been incorporated into various new smartphones and wearable devices such as, smartwatches and fitness wristbands making it readily available to all consumers. This sensor can record biometrics such as, heart rate, blood pressure, oxygen saturation, etc.

Study Details

The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signals obtained from PPG in the general population. Finally, the investigators are also aiming to investigate the association between signals obtained from PPG in the general population to cardioechographic findings such as, valvular heart disease, structural heart diseases, cardiomyopathies, pericardial disease etc.

Key Dates

Start date
Aug 20, 2021
Status verified
Mar 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: Patient Group
    All patients undergoing an echocardiogram at Tulane Medical Center may be asked to participate in the study. Doctors, including PI and co-PI, will identify eligible patients from their clinic using their clinical knowledge and expertise and the patients' medical history and records. They will provide patients with information regarding the study and if interested, patients will be consented prior to their scheduled echocardiogram.

Primary Outcome Measure

Association between obtained PPG waveforms and recorded ejection (EF) fractions. [ Time Frame: Day 1 ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
East Jefferson General HospitalNew OrleansLouisiana70006
Mayana Bsoul, MD
[email protected]
504-988-3063
Kunal Sameer, MD, MHA
[email protected]
504-988-3072
Nassir Marrouche, MD (PRINCIPAL_INVESTIGATOR)
Tulane Doctors - Speciality Care - NapoleonNew OrleansLouisiana70115
Mayana Bsoul, MD
[email protected]
504-988-3063
Kunal Sameer, MD, MHA
[email protected]
504-988-3072
Nassir Marrouche, MD (PRINCIPAL_INVESTIGATOR)
University Medical CenterNew OrleansLouisiana70112
Mayana Bsoul, MD
[email protected]
504-988-3063
Kunal Sameer, MD, MHA
[email protected]
504-988-3072
Nassir Marrouche, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New Orleans, LA

By research site
East Jefferson General Hospital· New Orleans, LATulane Doctors - Speciality Care - Napoleon· New Orleans, LAUniversity Medical Center· New Orleans, LA

Related Studies